Company profile
INVO Fertility, Inc.
NASDAQ: IVF · Healthcare · Medical - Devices
#673 of 1,418 Healthcare companies by revenue48th-percentile growth
EA Score
43DFH 40DQ 43GM 56SS 37
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, disclosure history · ↓ filing timeliness, return on equity
Methodology →Revenue TTM
$7.2M
Rev growth YoY (TTM)
+9.5%
Net income (FY)
-$23.3M
Employees
41
as of 2026-08-25
Market cap
$1.8M
as of 2026-08-25
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.8M$6.8M2025
Net income-$23.3M-$23.3M2025
Operating income-$7.2M-$7.2M2025
Total assets$20.2M$20.2M2025
Liabilities$13.0M$13.0M2025
Equity$7.2M$7.2M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Clinic Revenue98%
Product2%
By geography
Not disclosed.
The read
What is INVO Fertility, Inc.’s revenue?
INVO Fertility, Inc. booked $6.8M in FY2025 revenue, growing 4.3% year over year — about the middle of the pack among Healthcare companies we track, at a -340.9% net margin.
Peers · Healthcare
T2 Biosystems, Inc.——Whitehawk Therapeutics Inc50DImmunome, Inc.47DMedite Cancer Diagnostics, Inc.——Reliq Health Technologies Inc.——Pacific Health Care Organization, Inc.74BNeighbors
Sarasota →Key facts
CEOSteven Shum
SectorHealthcare
IndustryMedical - Devices
HeadquartersSarasota, FL
ExchangeNASDAQ: IVF
Employees41
IPO date2020-11-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.